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INTRODUCTION
Progress in three-dimensional (3D) echocardiography
was rather slow in the 1980s and 1990s mainly due to
technical reasons. Recently, along with the rapid evolu-
tion in probe and computer technologies 3D has grown
into a well-developed technique able to display images of
the heart that contain important new tissue and morpho-
logic information. This new technique is now simple and
rapid, and allows additional clinical information in differ-
ent fields including valve diseases, volume and function
of the two ventricles, intracardiac masses, monitoring
new procedures and several other topics (1-3).
This review details the current status of 3D technolo-
gy with its clinical applications in valve disease.
METHODS AND NEW TECHNOLOGIES
Several methods including random and sequential
scanning, free-hand techniques by both transthoracic
and transesophageal echocardiography have been pro-
posed in the past and all of them required an off-line re-
construction. Real-time volumetric echocardiography
developed in the early 1990s by von Ramm et al of Duke
University (4) was based on novel matrix phased array
transducer technology. However, the first generation in-
strument had several practice limitations despite its po-
tential but very promising clinical applications were
clearly demonstrated. In 2000, the second generation
real-time live 3D (and currently the new probe and soft-
ware technologies) allowed a true routine application of
the method in different fields: it is simple, rapid and can
be easily integrated and associated with the standard
2D examination. In brief, these new transducers (with
3000/4000 ultrasound elements) generate multidirec-
tional beam steering and signal processing, which
take place automatically in the scanning probe itself.
This technology generates true pyramidal volumes of
data in the display and creates on-line rendered im-
ages; since this pyramidal data set is still limited in
terms of volume (generally 60° x 30°), it is possible to
obtain a larger volume data set of up to 100° x 100°
(the so-called full volume data set) acquiring together
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up to seven (generally five) sub volumes over con-
secutive cardiac cycles. Images acquired can be im-
mediately sliced in several planes and rotated in or-
der to visualize cardiac structures from any plane
and multiple perspectives (5). 
Concerning the “old technologies” 3D sequential trans-
esophageal acquisition (multiplane transesophageal
echocardiography (TEE) with ECG and respiratory gat-
ing or new techniques with very fast acquisition without
gating) is still utilized and very useful in several clinical
settings (6-9). Therefore, in this review we refer to real-
time transthoracic (3DTTE) and transesoephagel se-
quential acquisition (3DTEE).
Figures 1 and 2 show 3D examples of normal aortic,
mitral and tricuspid valves.
MITRAL VALVE DISEASE
Both qualitative and quantitative evaluation of valvu-
lar heart disease can be improved by 3D echocardiog-
raphy. Anyplane and paraplane analysis of a stenotic
valve allows an accurate planimetry of the smallest ori-
fice area. Zamorano et al (10) demonstrated that 3DTTE
is a feasible, accurate and highly reproducible tech-
nique for assessing the mitral valve (MV) area in pa-
tients with rheumatic MV stenosis. In a consecutive se-
ries of 80 patients, MV area was assessed by conven-
tional echo-Doppler methods and by 3DTTE, and re-
sults were compared with those obtained invasively.
Compared with all other echo-Doppler methods,
3DTTE had the best agreement with the invasively de-
termined MV area, and intra- and inter-observer vari-
ability of the method was very good. Zamorano et al
(11) also studied 29 patients undergoing percutaneous
balloon mitral valvuloplasty. 3DTTE had the best agree-
ment with the invasively determined MV area, particu-
larly in the immediate post procedural period; there-
fore, the method could be proposed as an ideal one
throughout this procedure and could make invasive
evaluation unnecessary in this setting.
Fig. 1 - 3DTTE recon-
struction of a normal
aortic valve: diastolic
(left panel) and systolic
(right panel) frames of
the valve showing ac-
curate evaluation of
the leaflets and com-
missures.
AO = aortic valve; LA =
left atrium.
Fig. 2 - Surgical view of the mitral and tricuspid valves (diastolic
frame). MV = mitral valve; TV= tricuspid valve.   Colombo et al
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As part of these very important quantitative data,
3DTTE can be integrated with 2D evaluation in the
qualitative morphology assessment of the MV. Com-
missures, leaflets, annulus calcifications and sub-
valvular structures can be visualized from different and
unique planes facilitating the understanding of this
complex apparatus. Each of the atrioventricular valves
can be depicted both from the atrium or the ventricle
with access to “en face” views or from any other angle.
Vegetations, commissural diseases, subvalvular patho-
logies (tip of the leaflets/chordae/papillary muscles),
clefts can be accurately diagnosed.
MV prolapse is visualized as a bulge or protrusion
on the atrial site, and in this regard 3D is the ideal
method to demonstrate the pathology. Several studies
by 3DTEE and 3DTTE have demonstrated the impor-
tance of 3D methods in this field (12-18). Recent data
have demonstrated that 3D (either transthoracic or
transesophageal) echocardiography is superior in
comparison with the corresponding 2D techniques in
the description of MV pathology. In particular, since re-
al-time 3DTTE has an accuracy similar to that of 2D
transesophageal echocardiography, this new tech-
nique (which is also simple and rapid) can be integrat-
ed in the standard 2D examination and should be re-
garded as an important examination in decisions re-
garding MV repair. MV prolapse is the most frequent
etiology of mitral regurgitation in industrialized coun-
tries. Since the 1970s, MV repair has become prefer-
ential to replacement, and it is now possible in the
overwhelming majority of patients with MV prolapse
(19, 20). Recent studies and guidelines have under-
lined the importance of early surgical intervention to
preserve long-term left ventricular function in severe
mitral regurgitation. In this regard, a non-invasive pre-
operative assessment of MV anatomy is essential to
define the feasibility and complexity of repair, differen-
tiating cases with simple or complex lesions and to
plan the ideal surgical strategy. For these reasons,
3DTTE and 3DTEE should be regarded as an important
examination in decisions regarding MV repair, particu-
larly in cases with complex diseases and in the light of
these new early surgical strategies. Recently, a large
series of cases with MV prolapse evaluated with differ-
ent echo methods was published by our group (21).
One hundred and twelve consecutive patients with se-
vere mitral regurgitation due to degenerative MV pro-
lapse underwent a complete 2D and 3DTTE the day
before surgery, and a complete 2D and 3DTEE in the
operating theater. Echocardiographic data obtained by
the different techniques (including scallops, commis-
sures, chordal rupture identification) were compared
with MV surgical inspection. 3D techniques were feasi-
ble in a relatively short time (3DTTE 7 ± 4 min; 3DTEE 8
± 3 min), with good (3DTTE 55%; 3D TEE 35%) and op-
timal (3DTTE 21%; 3DTEE 45%) imaging quality in the
majority of cases. 3DTEE allowed more accurate iden-
tification (95.6% accuracy) of all MV lesions in com-
parison with other techniques. 3DTTE and 2DTEE had
similar accuracies (90 and 87%, respectively), while
the accuracy of 2DTTE (77%) was significantly lower.
Therefore, these data showed that 3DTTE and 3DTEE
are feasible, not time consuming and useful methods
in identifying the location of MV prolapse in patients
undergoing MV repair. They were superior in the de-
scription of pathology in comparison with the corre-
sponding 2D techniques and should be regarded as an
important adjunct to standard 2D examinations in de-
cisions regarding MV repair.  
Figure 3 shows four cases of MV prolapse examined
by 3DTTE and 3DTEE, respectively.
AORTIC VALVE DISEASE
The aortic valve can be easily evaluated by 3DTTE
or 3DTEE. The morphology of the valve can be defined
with high accuracy demonstrating the normality of the
cusps, congenital abnormalities (bicuspid aortic
valve) or acquired pathologies (Fig. 4). Few data have
concentrated on the accuracy of 3D in the assess-
ment of the severity of aortic valve stenosis (22). Re-
cently Goland et al (23) evaluated the reproducibility
and accuracy of real-time 3DTTE in 33 patients with
aortic stenosis. Aortic valve area by 3DTTE was com-
pared with 2DTTE planimetry, 2DTEE planimetry and
in 15 cases with invasive measurements. Statistical
analysis showed good agreement and small absolute
differences in aortic valve area between all planimetric
methods. Inter-observer variability was better for 3D
techniques. Therefore, the authors suggested that
this very rapid and novel method provided an accu-
rate and reliable quantitative assessment of aortic
stenosis. 3D echocardiography in valve disease
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Fig. 3 - Four cases of
mitral valve disease.
Upper left: 3DTTE re-
construction in a pa-
tient with mitral valve
prolapse of the entire
posterior leaflet (Bar-
low disease) with the
three prolapsing scal-
lops (arrow). Upper
right: 3DTTE recon-
struction in a mitral
valve with a central
cleft of the posterior
leaflet (arrow). Lower
left: 3DTEE recon-
struction in a patient
with an isolated pro-
lapse of the anterolat-
eral scallop of posteri-
or leaflet (P1) (arrow).
Lower right: 3DTEE
reconstruction in a mi-
tral valve with a cleft
and prolapse of the
medial scallop (P2)
(arrow). MVPL = mitral
valve posterior leaflet.
Fig. 4 - Two examples of
bicuspid aortic valves.
Left panel: 3DTTE re-
construction of a bi-
cuspid valve in a sys-
tolic frame showing
the two cusps and the
rafe (arrow). Right pan-
el: 3DTEE reconstruc-
tion (systolic frame) of
a bicuspid valve. AO =
aortic valve.Colombo et al
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TRICUSPID VALVE DISEASE
3D echocardiography offers a direct view to evaluate
the leaflet surface of the tricuspid valve, and is a unique
method to visualize the three leaflets simultaneously.
Potentially, this offers the opportunity to study every tri-
cuspid pathology from different perspectives such as
from the right ventricle, from the right atrium or from the
oblique planes. Leaflet coaptation and separation can
be visualized easily. Even though consecutive series of
cases with tricuspid valve disease have not been pub-
lished, and no data demonstrate an additional clinical
value of the method, several case reports have demon-
strated the importance of this technique in Ebstein’s
anomaly (24), tricuspid stenosis (25) and other tricuspid
pathologies. This potential in different tricuspid
pathologies could be further completed by the mea-
surement of right ventricular volumes and function
(ejection fraction) by off-line 3DTTE analysis. In all tri-
cuspid pathologies a crucial point is represented by
right ventricular function and the calculation of right
ventricular volumes is not feasible by conventional 2D
echocardiography. Full volume analysis by 3DTTE al-
lows, in a few seconds, the acquisition of a complete
data set of the right ventricle and off-line calculation of
right ventricular volume, as well as recognition of tricus-
pid disease.  
FUTURE CLINICAL APPLICATION OF 3D
ECHOCARDIOGRAPHY IN VALVE DISEASES
Standard 2D echocardiography is a well-established
method to evaluate infective endocarditis and its com-
plications. However, 3D echocardiography can facilitate
the description of any cardiac mass site, and in this field
could provide information regarding the attachment and
morphology of the vegetations as well as their dimen-
sions. Moreover, through 3D and color Doppler 3D, the
perforation and severity of lesions can be studied bet-
ter. Further studies are needed to define whether these
new technologies could also increase the accuracy in
the differential diagnosis between vegetations and oth-
er valve masses such as fibroelastomas, mixomas or
degenerative diseases.
Stress echocardiography may be very useful in valve
disease. 3D echocardiography offers the unique possi-
bility to visualize the left ventricle during one breath
hold; and therefore, peak exercise (or peak dobutamine)
volumes and function can be calculated. Simultaneous-
ly, all other information (Doppler data, 3D volumes of re-
gurgitant jets) can be acquired. Therefore, potentially
this method could be considered ideal for the stress
evaluation of patients with MV regurgitation, MV steno-
sis and aortic valve regurgitation. 
FUTURE TECHNICAL DEVELOPMENTS
Several technical advancements will improve 3D
technologies further. Size of matrix transducers, spatial
and temporal resolution could be optimized increasing
the feasibility of the examination in all clinical settings
and increasing the resolution and quality of the exami-
nations.
New software is going to be developed facilitating the
morphologic and quantitative evaluation of structures.
New methodologic approaches to 3D evaluation of MV
annulus (26), MV tracking and left and right ventricular
functional analysis (27), have been recently proposed.
All these new systems could increase the rapidity and
feasibility and clinical value of routine examination,
stress echocardiography and contrast studies.
3D color Doppler flow mapping is already implement-
ed in the ultrasound 3D units; however, even though
several studies have already been published concern-
ing the clinical value of this method (28) in the quantita-
tive approaches to valve regurgitant jets and shunt le-
sions, further technical improvements are needed to in-
clude this technology in a routine exam. 
A new and revolutionary method will very soon be im-
plemented in the cardiological examination. Due to ad-
vances in both micro industrial design and size of matrix
transducers, prototypes of 3D transesophageal real-
time transducers have been integrated in new equip-
ment. Images from these new transducers (TEE probes
with dimensions similar to a standard multiplane probe)
can be obtained from any transesophageal position in
real time, just with one touch of the keyboard that con-
verts the standard 2D image into a rendering 3D/4D
view of the visualized structures (without any cropping
or reconstruction of the data set). Therefore, we could
postulate that in a few years all 2DTEE studies might be
integrated by 3DTEE imaging with obvious clinical value3D echocardiography in valve disease
40
in all clinical settings. Preliminary data show that intra-
operative monitoring of cardiac surgery, monitoring of
PFO or interatrial septal defect, mitral and aortic valve
diseases could be several fields in which this technolo-
gy could become the standard echocardiographic ex-
amination procedure.
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